<DOC>
	<DOCNO>NCT00567970</DOCNO>
	<brief_summary>RATIONALE : Stereotactic radiation therapy may able send x-ray directly tumor cause less damage normal tissue . PURPOSE : This phase I trial study side effect best dose stereotactic radiation therapy treat patient liver metastasis .</brief_summary>
	<brief_title>Stereotactic Radiation Therapy Treating Patients With Liver Metastases</brief_title>
	<detailed_description>OBJECTIVES : - To identify maximum tolerate dose stereotactic radiation therapy patient hepatic metastasis . - To determine toxicity adverse event profile patient population . - To examine patient response , treatment effect blood chemistry , hematology value patient quality-of-life patient population . OUTLINE : Patients stratify accord stereotactic radiotherapy level ( 1 vs 2 v 3 ) number liver lesion present ( 1-2 v 3-5 v &gt; 5 ) . Patients undergo percutaneous placement metallic fiducial marker within liver stereotactic target planning . Patients undergo 1 fraction stereotactic radiotherapy within 1 week marker placement . Patients complete Brief Pain Inventory Brief Fatigue Inventory questionnaires assess quality life week 2 , 4 , 6 , 8 month 3 , 6 , 9 completion study treatment . After completion study treatment , patient follow least 8 week .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Metastatic liver lesion ≤ 5 cm dimension Willing able undergo percutaneous placement localization seed PATIENT CHARACTERISTICS : ECOG performance status 01 Life expectancy ≥ 12 week Platelet count ≥ 75,000/µL Hemoglobin ≥ 9 g/dL ANC ≥ 1,500/mL Total bilirubin ≤ 1.5 x upper limit normal ( ULN ) AST ≤ 3 x ULN Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception Able complete questionnaire alone assistance No medical , social , economic circumstance , likely prevent adherence protocol PRIOR CONCURRENT THERAPY : No prior radiation therapy liver No chemotherapy ≤ 4 week prior registration Able safely go without chemotherapy 4 week stereotactic radiotherapy ( e.g. , patient must need chemotherapy 8 week [ 4 week prior 4 week registration ] surround stereotactic radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>liver metastasis</keyword>
</DOC>